XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.8610
-0.0390 (-4.33%)
At close: Nov 19, 2025, 4:00 PM EST
0.8400
-0.0210 (-2.44%)
After-hours: Nov 19, 2025, 5:36 PM EST
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $8.33 million as of November 19, 2025. Its market cap has decreased by -71.28% in one year.
Market Cap
8.33M
Enterprise Value
7.22M
1-Year Change
-71.28%
Ranking
Category
Stock Price
$0.86
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $8.33M, a decrease of -95.37%. That is a compound annual growth rate of -14.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 8.33M | -62.78% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | 15.68M | 124.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 921.68B |
| Johnson & Johnson | 481.09B |
| AbbVie | 417.33B |
| UnitedHealth Group | 285.16B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 234.43B |
| Abbott Laboratories | 228.98B |